199 related articles for article (PubMed ID: 23090561)
1. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
Committee on Gynecologic Practice
Obstet Gynecol; 2012 Nov; 120(5):1239-42. PubMed ID: 23090561
[TBL] [Abstract][Full Text] [Related]
2. Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
Heinemann K; Heinemann LA
J Fam Plann Reprod Health Care; 2011 Jul; 37(3):132-5. PubMed ID: 21659330
[No Abstract] [Full Text] [Related]
3. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
Lidegaard Ø; Nielsen LH; Skovlund CW; Skjeldestad FE; Løkkegaard E
BMJ; 2011 Oct; 343():d6423. PubMed ID: 22027398
[TBL] [Abstract][Full Text] [Related]
4. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
Reid R;
J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
6. Drospirenone Litigation: Does the Punishment Fit the Crime?
Batur P; Casey PM
J Womens Health (Larchmt); 2017 Feb; 26(2):99-102. PubMed ID: 27854556
[TBL] [Abstract][Full Text] [Related]
7. Do drospirenone-containing oral contraceptives have a higher risk of VTE?
Ribowsky JH
JAAPA; 2011 Aug; 24(8):51-3. PubMed ID: 21850920
[No Abstract] [Full Text] [Related]
8. Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis.
Bateson D; Butcher BE; Donovan C; Farrell L; Kovacs G; Mezzini T; Raynes-Greenow C; Pecoraro G; Read C; Baber R
Aust Fam Physician; 2016; 45(1):59-64. PubMed ID: 27051991
[TBL] [Abstract][Full Text] [Related]
9. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.
Jick SS; Hernandez RK
BMJ; 2011 Apr; 342():d2151. PubMed ID: 21511805
[TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
Parkin L; Sharples K; Hernandez RK; Jick SS
BMJ; 2011 Apr; 342():d2139. PubMed ID: 21511804
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
Dinger J; Bardenheuer K; Heinemann K
Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
[TBL] [Abstract][Full Text] [Related]
12. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
14. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.
Wu CQ; Grandi SM; Filion KB; Abenhaim HA; Joseph L; Eisenberg MJ
BJOG; 2013 Jun; 120(7):801-10. PubMed ID: 23530659
[TBL] [Abstract][Full Text] [Related]
15. Drospirenone and VTE.
Leppée M; Eric M; Culig J
J Fam Plann Reprod Health Care; 2010 Jan; 36(1):44. PubMed ID: 20067674
[No Abstract] [Full Text] [Related]
16. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
Raymond EG; Burke AE; Espey E
Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
[TBL] [Abstract][Full Text] [Related]
17. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.
Larivée N; Suissa S; Khosrow-Khavar F; Tagalakis V; Filion KB
BJOG; 2017 Sep; 124(10):1490-1499. PubMed ID: 28276140
[TBL] [Abstract][Full Text] [Related]
18. Debating the evidence: oral contraceptives containing drospirenone and risk of blood clots.
Dodd S
Curr Drug Saf; 2011 Jul; 6(3):132-3. PubMed ID: 22122386
[No Abstract] [Full Text] [Related]
19. Oral hormonal contraception and venous thromboembolism (VTE).
Reid RL
Contraception; 2014 Apr; 89(4):235-6. PubMed ID: 24594431
[No Abstract] [Full Text] [Related]
20. Another flawed database study.
Szarewski A; Mansour D; Shapiro S
Contraception; 2013 Apr; 87(4):505-6. PubMed ID: 23261232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
